Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(33)
•••
Inthepez
X
Comment by
Inthepez
on Mar 04, 2024 9:57am
RE:Ouch
Buy when there is blood in the streets lol
(4)
•••
Lostchannel
X
Post by
Lostchannel
on Mar 04, 2024 9:38am
Ouch
Too late to do anything now. Next big question- double down with the inevitable price crash or capitulation and walk away with huge loss?
Blue Sky Uranium Advances Ivana Project with Metallurgical Test Program
posted May 12, 2026 9:00am by
Blue Sky Uranium Corp.
-
|
The Company announced that its joint venture operating company Ivana Minerales S.A. has executed service agreements with M3 Engineering & Technology and the Saskatchewan Research Council to support engineering and metallurgical testing programs for the Ivana Uranium-Vanadium Project in Argentina ...read more
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 04, 2024 9:13am
For those
who converted their warrants. they have got to be steaming mad, every time they trust the company they get burned. when you think about it antibe has been nothing but a big disappointmnet, you have to
...more
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 04, 2024 8:31am
Big Hit
to the company 20M +4M interest, this is why i dumped all my shares above $1.05 last week the risk was just to great. and now the uncertainty going forward. a cash raise is now on the table sooner
...more
(5)
•••
Amigo11
X
Post by
Amigo11
on Mar 04, 2024 8:15am
Toast
$24 mill US owing and no cash flow -oops !
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 04, 2024 7:04am
New Press Release - Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain and inflammation, today announced that the arbitrator has found in favor of Nuance Pharma in the dispute regarding the license agreement for the...
read article.
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 02, 2024 8:00pm
Investors
are a bit weary of getting in because of the elephant in the room "arbitration decision" and for good reason, should ATE be stuck with the bill there likely will be a buying opportunity at
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Mar 01, 2024 9:35pm
RE:RE:RE:RE:If ATE
From a shareholder with warrants perspective - If you truly want shares, you bought at 50 cents or you buy now - below a dollar. you already have shares and the warrants are your bonus ... if bonus
...more
(8)
•••
Montana5
X
Comment by
Montana5
on Mar 01, 2024 10:08am
RE:RE:RE:If ATE
Mugs, it's only easy access to cash if the warrant holders see upside value in the conversion. Time will tell how many of the warrant holders convert. For those that do convert their warrants, are
...more
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 01, 2024 9:45am
Another Week
gone by still no news release of the decision, maybe an end of day news drop?
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 29, 2024 9:51pm
RE:RE:If ATE
Pimping the warrants for easy access to $6.5 MM in cash but that's a March 29th decision for warrant holders ... and then potentially a July 29th decision. If you are going to lose a partner
...more
(8)
•••
Montana5
X
Comment by
Montana5
on Feb 29, 2024 4:54pm
RE:If ATE
Maybe that is why they've been 'pimping' the warrants.
(1512)
•••
Duster340
X
Post by
Duster340
on Feb 27, 2024 10:44am
If ATE
is on the hook for a big part of that 20M. i think the stock will get a beatdown on the news.
(1512)
•••
Duster340
X
Post by
Duster340
on Feb 27, 2024 10:28am
How long
does it take to cross some T's and dot some i's form feb/14th: Arbitration with Nuance Pharma: the parties have been advised that the decision has been filed and will
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 23, 2024 8:51pm
RE:RE:Lots of dillution😮
Wait until March 30 (or so) to make a decision on your $1 warrants. You can always wait to July for a decision at $1.50 no rush !!!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
AI Beyond the Data Center: The Rise of Computing Everywhere
Podcasts